The inspection was done in the context of thematic supervision, meaning it was a proactive assessment of healthcare providers offering (partially) digital care. This means it was not a response to a complaint or specific risk.

The inspection confirmed that Clear.bio provides safe, high-quality care for people with type 2 diabetes. The IGJ recognized the value of our digital approach: using continuous glucose monitoring, our smart app, and the support of our dedicated dietitians. They noted that our method helps patients manage their glucose levels effectively and that we are continuously working to improve the care we deliver.

The inspectors also reviewed our internal processes, information security, and focus on clinical effectiveness. A few points for improvement were shared: mainly around strengthening some reporting procedures, and we are already putting those into action.

Most importantly, the IGJ has closed the inspection, meaning they are confident in the way we provide care.

This is an important milestone for us, and we couldn’t have achieved it without our amazing team and the trust of our patients and partners. Together, we are proving that digital care can make a real difference for people living with type 2 diabetes.

💡 Curious to learn more? The IGJ report and our formal response can be accessed here.

Thank you for being part of this journey with us.D